Laboratory Workup for Adult Female with Elevated TSH and Low Free T4
In an adult female with elevated TSH and low free T4 confirming overt primary hypothyroidism, measure anti-thyroid peroxidase (TPO) antibodies to identify autoimmune etiology, and assess for adrenal insufficiency if clinically indicated before initiating treatment 1.
Diagnostic Confirmation
You already have the two essential tests confirming overt primary hypothyroidism:
- Elevated TSH = pituitary responding appropriately to low thyroid hormone
- Low free T4 = inadequate thyroid hormone production
This pattern distinguishes overt from subclinical hypothyroidism (where free T4 would be normal) 2.
Essential Additional Testing
Anti-TPO Antibodies
Measure anti-thyroid peroxidase antibodies to establish whether this is autoimmune (Hashimoto's) thyroiditis, the most common cause of primary hypothyroidism in adults 1. This information:
- Confirms etiology
- Provides prognostic information
- May influence monitoring frequency
- Helps counsel the patient about the chronic nature of their condition
Rule Out Adrenal Insufficiency (Critical Safety Step)
Before starting levothyroxine, assess for adrenal insufficiency if the patient has:
- Symptoms suggesting hypocortisolism (hypotension, hyponatremia, hypoglycemia)
- History of pituitary disease
- Severe, long-standing hypothyroidism
This is crucial because initiating thyroid hormone replacement in someone with unrecognized adrenal insufficiency can precipitate adrenal crisis 1. The guideline explicitly states that patients with adrenal insufficiency or at risk for it should receive appropriate hydrocortisone doses until adrenal insufficiency is ruled out 1.
Tests That Are NOT Needed
T3 Measurement
Do not routinely measure T3 1. The guidelines are clear that T3 levels lack sufficient specificity for diagnosis or therapeutic monitoring. T3 may be in the lower reference range or even mildly subnormal in treated hypothyroidism without clinical significance 1.
Repeat TSH/Free T4
The diagnosis is already established with one set of abnormal values showing the classic pattern. Repeating these tests before treatment adds no value.
Thyroid Imaging
Ultrasound or radionuclide scanning is not indicated for straightforward primary hypothyroidism unless there are palpable nodules or goiter on physical examination.
Clinical Context Matters
Pregnancy Status
If this patient is pregnant or contemplating pregnancy, this becomes urgent as hypothyroidism requires immediate treatment to prevent pregnancy complications and impaired fetal cognitive development 2.
Cardiovascular Assessment
Before initiating treatment, particularly in older women or those with cardiac risk factors, assess for coronary artery disease as this influences starting dose. The guidelines recommend starting at 12.5-25 µg/day in patients with known coronary disease versus full replacement doses in younger patients 1.
Common Pitfalls to Avoid
- Do not delay treatment to obtain antibody results—you can start levothyroxine while awaiting TPO antibodies
- Do not order comprehensive thyroid panels with multiple unnecessary tests (total T4, total T3, thyroglobulin, TSH receptor antibodies)—these add cost without benefit
- Do not assume central hypothyroidism with this pattern (elevated TSH + low free T4 = primary hypothyroidism by definition)
Summary Algorithm
For adult female with elevated TSH + low free T4:
- Order anti-TPO antibodies (establishes autoimmune etiology)
- Assess adrenal function if clinically indicated (prevents adrenal crisis)
- Initiate levothyroxine at appropriate dose based on age and cardiac status
- Recheck TSH in 6-8 weeks after starting treatment (this becomes your monitoring parameter)
The target TSH for treatment is 0.45-4.12 mIU/L based on NHANES III data, though some controversy exists about optimal targets 1.